Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Trial of Xoft® Intraoperative Radiotherapy (IORT) as a Component of Breast Conserving Therapy (BCT) in Patients With Early-Stage Breast Cancer

NCT04088435 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT04088435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Trial of Xoft® Intraoperative Radiotherapy (IORT) as a Component of Breast Conserving Therapy (BCT) in Patients With Early-Stage Breast Cancer
Lead sponsor
University of Louisville
Phase
Observational
Overall status
Terminated
Start date
September 10, 2019
Completion date
June 5, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer stage i, breast cancer stage iia, breast cancer, invasive ductal, invasive mammary carcinoma